4//SEC Filing
Alspaugh Jonathan 4
Accession 0001209191-23-012875
CIK 0001636282other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:20 PM ET
Size
5.5 KB
Accession
0001209191-23-012875
Insider Transaction Report
Form 4
Alspaugh Jonathan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-23+640,000→ 640,000 totalExercise: $0.44Exp: 2033-02-22→ Common Stock (640,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 23, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001868112
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:20 PM ET
- Size
- 5.5 KB